Story excerpt provided by Crain’s Cleveland Business.
ViewRay Inc. (Nasdaq: VRAY) of Oakwood Village has made the first sale in Japan of its MRI-guided radiation therapy system, MRIdian.
The sale to the National Cancer Center (NCC) in Tokyo comes about a month after ViewRay received approval from the Japanese Ministry of Health, Labor and Welfare to market MRIdian in the country.
Click here to read the complete article.
Originally published September 21, 2016.